High Resolution HBA-MRI Using Deep Learning Reconstruction

Sponsor
Seoul National University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05182099
Collaborator
GE Healthcare (Industry)
52
1
2
8.6
6

Study Details

Study Description

Brief Summary

This study aims to compare image qualities between conventionally reconstructed MRI sequences and deep-learning reconstructed MRI sequences from the same data in patients who undergo Gd-EOB-DTPA enhanced liver MRI. The AIRTM deep learning sequence is applicable for various MRI sequences including T2-weighted image (T2WI), T1-weighted image and diffusion-weighted image (DWI). We plan to perform intra-individual comparisons of the image qualities between two reconstructed image datasets.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Liver MRI
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
blinded to the reconstruction types
Primary Purpose:
Diagnostic
Official Title:
AIRTM Deep Learning Reconstruction of Abdominal High Resolution Gd-EOB-DTPA Enhanced MRI in Patients With Suspicious Focal Liver Lesions: Image Quality Assessment
Actual Study Start Date :
Jan 10, 2022
Actual Primary Completion Date :
Mar 30, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Conventional image reconstruction

Gd-EOB-DTPA enhanced liver MRI images are reconstructed using a conventional image reconstruction algorithm. It is automatically generated from a MRI console after the examination.

Diagnostic Test: Liver MRI
Gd-EOB-DTPA enhanced MRI consists of T2-weighted image (T2WI), diffusion weighted image (DWI) and precontrast T1-weighted image (T1WI), dynamic T1WI (arterial, portal and transitional phases), and hepatobiliary phase.

Active Comparator: Deep learning image reconstruction

Gd-EOB-DTPA enhanced liver MRI images are reconstructed using a deep learning based image reconstruction algorithm (AIRTM). It is additionally generated aside from the conventional images. For obtaining the images, we will use the same MRI raw data which is used for conventional image reconstruction.

Diagnostic Test: Liver MRI
Gd-EOB-DTPA enhanced MRI consists of T2-weighted image (T2WI), diffusion weighted image (DWI) and precontrast T1-weighted image (T1WI), dynamic T1WI (arterial, portal and transitional phases), and hepatobiliary phase.

Outcome Measures

Primary Outcome Measures

  1. Overall image quality of arterial phase [3 months after enrollment completion]

    qualitative assessment of arterial phase on a five point scale (highest score indicates better image quality)

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • older than 20 years old

  • scheduled for Gd-EOB-DTPA enhanced liver MRI at a 3T scanner (Premier, GE Healthcare) in our institution

  • signed informed consent

Exclusion Criteria:
  • younger than 20 years old

  • any absolute/relative contrast indication of Gd-EOB-DTPA enhanced MRI

  • history of transient dyspnea after Gd-EOB-DTPA administration

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Seoul National University Hospital
  • GE Healthcare

Investigators

  • Principal Investigator: Jeong Min Lee, MD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeong Min Lee, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05182099
Other Study ID Numbers:
  • 2021-3044
First Posted:
Jan 10, 2022
Last Update Posted:
Apr 5, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022